Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice.

Zarantonelli ML, Antignac A, Lancellotti M, Guiyoule A, Alonso JM, Taha MK.

J Antimicrob Chemother. 2006 May;57(5):924-30. Epub 2006 Mar 2.

PMID:
16513914
2.

Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex.

Lancellotti M, Guiyoule A, Ruckly C, Hong E, Alonso JM, Taha MK.

Microbes Infect. 2006 Jan;8(1):191-6. Epub 2005 Aug 15.

PMID:
16182586
3.

Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages.

Touqui L, Paya M, Thouron F, Guiyoule A, Zarantonelli ML, Leduc D, Wu Y, Taha MK, Alonso JM.

FEBS Lett. 2005 Sep 12;579(22):4923-7.

4.

The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia.

Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, Alonso JM.

Clin Infect Dis. 2003 Dec 15;37(12):1639-42. Epub 2003 Nov 17.

PMID:
14689345
5.

Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns.

Antignac A, Ducos-Galand M, Guiyoule A, Pirès R, Alonso JM, Taha MK.

Clin Infect Dis. 2003 Oct 1;37(7):912-20. Epub 2003 Sep 9.

PMID:
13130402
6.

A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice.

Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, Antignac A, Deghmane AE, Huerre M, van der Werf S, Taha MK.

FEMS Microbiol Lett. 2003 May 16;222(1):99-106.

7.

Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis.

Guiyoule A, Gerbaud G, Buchrieser C, Galimand M, Rahalison L, Chanteau S, Courvalin P, Carniel E.

Emerg Infect Dis. 2001 Jan-Feb;7(1):43-8.

8.

Failure of oily chloramphenicol depot injection to treat plague in a murine model.

Rahalison L, Guiyoule A, Bonacorsi SP, Slacanin I, Chanteau S, Carniel E.

J Antimicrob Chemother. 2000 Apr;45(4):541-5.

PMID:
10747836
9.

High homogeneity of the Yersinia pestis fatty acid composition.

Leclercq A, Guiyoule A, El Lioui M, Carniel E, Decallonne J.

J Clin Microbiol. 2000 Apr;38(4):1545-51.

10.

Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis.

Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14043-8. Erratum in: Proc Natl Acad Sci U S A 2000 Jul 5;97(14):8192.

11.
12.

The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes.

Buchrieser C, Brosch R, Bach S, Guiyoule A, Carniel E.

Mol Microbiol. 1998 Dec;30(5):965-78.

13.

Phenotypic and genotypic characterization of virulent yersinia enterocolitica strains unable to ferment sucrose.

Guiyoule A, Guinet F, Martin L, Benoit C, Desplaces N, Carniel E.

J Clin Microbiol. 1998 Sep;36(9):2732-4.

14.

Recent emergence of new variants of Yersinia pestis in Madagascar.

Guiyoule A, Rasoamanana B, Buchrieser C, Michel P, Chanteau S, Carniel E.

J Clin Microbiol. 1997 Nov;35(11):2826-33.

15.

Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Galimand M, Guiyoule A, Gerbaud G, Rasoamanana B, Chanteau S, Carniel E, Courvalin P.

N Engl J Med. 1997 Sep 4;337(10):677-80. No abstract available.

16.

[Serodiagnosis of human pathogenic Yersinia infections].

Benoit C, Guiyoule A, Carniel E.

Presse Med. 1996 Nov 9;25(34):1627-30. French.

PMID:
8952682
17.

Comparison of three molecular methods for typing and subtyping pathogenic Yersinia enterocolitica strains.

Iteman I, Guiyoule A, Carniel E.

J Med Microbiol. 1996 Jul;45(1):48-56.

PMID:
8667412
18.

Susceptibility to beta-lactam agents of Yersinia enterocolitica biotype 4, serotype O3 isolated in various parts of the world.

Pham JN, Bell SM, Hardy MJ, Martin L, Guiyoule A, Carniel E.

J Med Microbiol. 1995 Jul;43(1):9-13.

PMID:
7608962
19.

Comparison of beta-lactamase production by Yersinia enterocolitica biotype 4, serotype O:3 isolated in eleven countries.

Pham JN, Bell SM, Hardy MJ, Martin L, Guiyoule A, Carniel E.

Contrib Microbiol Immunol. 1995;13:180-3. No abstract available.

PMID:
8833828
20.

Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.

Bonacorsi SP, Scavizzi MR, Guiyoule A, Amouroux JH, Carniel E.

Antimicrob Agents Chemother. 1994 Mar;38(3):481-6. Erratum in: Antimicrob Agents Chemother 1994 Jul;38(7):1694.

21.

Plague pandemics investigated by ribotyping of Yersinia pestis strains.

Guiyoule A, Grimont F, Iteman I, Grimont PA, Lefèvre M, Carniel E.

J Clin Microbiol. 1994 Mar;32(3):634-41.

22.

Survey of the irp2 gene among Yersinia pestis strains isolated during several plague outbreaks in northeast Brazil.

deAlmeida AM, Guiyoule A, Leal NC, Carniel E.

Mem Inst Oswaldo Cruz. 1994 Jan-Mar;89(1):87-92.

23.
24.

Chromosomal irp2 gene in Yersinia: distribution, expression, deletion and impact on virulence.

de Almeida AM, Guiyoule A, Guilvout I, Iteman I, Baranton G, Carniel E.

Microb Pathog. 1993 Jan;14(1):9-21.

PMID:
8321119
25.

Molecular cloning, iron-regulation and mutagenesis of the irp2 gene encoding HMWP2, a protein specific for the highly pathogenic Yersinia.

Carniel E, Guiyoule A, Guilvout I, Mercereau-Puijalon O.

Mol Microbiol. 1992 Feb;6(3):379-88.

PMID:
1552851
26.

Chromosomal marker for the 'high pathogenicity' phenotype in Yersinia.

Carniel E, Guiyoule A, Mercereau-Puijalon O, Mollaret HH.

Contrib Microbiol Immunol. 1991;12:192-7. No abstract available.

PMID:
1935090
27.

Phenotypic characterization and virulence of O8 Yersinia strains isolated in Europe.

Chiesa C, Pacifico L, Guiyoule A, Ravagnan G, Mollaret HH.

Contrib Microbiol Immunol. 1991;12:182-91. No abstract available.

PMID:
1935089
28.
29.

Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.

Scavizzi MR, Alonso JM, Philippon AM, Jupeau-Vessieres AM, Guiyoule A.

Antimicrob Agents Chemother. 1987 Apr;31(4):523-6.

30.

[Yersinia enterocolitica septicaemia associated with Yersinia intestinal lesions detected by colonoscopy (author's transl)].

Vitaux J, Delaville MR, Gavillon C, Trousset M, Théodore C, Guiyoule A, Goullet P, Paolaggi JA.

Nouv Presse Med. 1981 Dec 5;10(44):3639-41. French.

PMID:
7322896
31.

[Detection and identification of bacteria of the genus Yersinia].

Chiesa C, Melis R, Guiyoule A.

Ann Sclavo. 1981 May-Jun;23(3):301-13. Review. Italian. No abstract available.

PMID:
7041835
32.

[Differentiation of "Pasteurella" and "Actinobacillus" from Enterobacteriaceae" by use of the O/129 vibriostatic agent (author's transl)].

Chatelain R, Bercovier H, Guiyoule A, Richard C, Mollaret HH.

Ann Microbiol (Paris). 1979 May-Jun;130 A(4):449-54. French.

PMID:
389129

Supplemental Content

Loading ...
Support Center